Exemestane
FDA status: FDA has approved products that contain exemestane, including Aromasin.
ClinicalTrials.gov: 398 registered studies. See all studies
- NCT04997798 Dalpiciclib in Combination With Exemestane and Trastuzumab Plus Pyrotinib in Early Triple Positive Breast Cancer (Phase 2), unknown
- NCT02392611 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer (Phase 1), completed
- NCT00201864 Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer (Phase 2), completed
MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 258494 ↗PubChem CID 60198 ↗Wikipedia ↗









